Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

New irrigation solution helps remove bacterial colonisation in chronic sinus infections

Medtronic : 29 November, 2007  (New Product)
Results of a research study suggest that pressurised irrigation of the sinuses in conjunction with a specially designed irrigation solution being developed by Medtronic may offer new options to reduce bacteria associated with chronic rhinosinusitis (CRS).
“Methods for Removing Bacterial Biofilms: In Vitro Study Using Clinical CRS Specimens,” led by Martin Desrosiers, MD, associate clinical professor in the Department of Otolaryngology and Allergy at Montreal General Hospital, McGill University in Montreal, Canada, showed a large reduction of robust and highly adherent bacterial colonies in a laboratory model.

Two strains of bacteria, Pseudomonas aeruginosa and Staphylococcus aureus, were clinically isolated from CRS patients who had poor outcomes following functional endoscopic sinus surgery. Authors of the study, which was presented at the spring meeting of the American Rhinologic Society in San Diego, California, USA, received the ARS Basic Science Research Award.

The bacterial strains were grown into robust bacterial colonies and treated with a variety of commonly used therapies including antibiotics and hypertonic saline. These existing therapies were compared to static and pressurised application of a new irrigation solution under development at Medtronic.

Of the S aureus and Pseudomonas bacterial colonies grown in this model, respectively 99.98 percent and 99.999 percent of the bacteria were removed by the pressurised application.

Researchers at McGill University in Montreal, Montana State and at Medtronic collaborated to test the effectiveness of pressurised irrigation with the citric acid zwitterionic surfactant irrigating solution. Bacteria isolated from failed surgical patients at McGill were sent to Montana State, grown into robust bacterial colonies, and treated with a number of static and dynamic irrigation solutions. Commonly used controls were compared to static and pressurised applications of the Medtronic surfactant.

Control groups included many of the currently used irrigation solutions, containing antibiotics (tobramycin and doxycycline), and salt water (isotonic and hypertonic saline). When applied statically, none of the controls had any material effect on the bacterial colony. Conversely, dynamic application of saline reduced the number of bacteria by 99.4 percent in both types of bacterial colonies.

Static application of the surfactant reduced the number of bacteria in the colonies of S aureus and Pseudomonas 99.66 percent and 99.87 percent respectively. The best results were achieved when surfactant was applied under pressure, where 99.98 percent and 99.999 percent of S aureus and Pseudomonas were removed equalling a four- (10,000x) and five- (100,000x) log reduction, respectively.

“Given the positive results of this laboratory study, we are initiating a number of studies to further evaluate this technology,” said Bo Lewis, senior director of marketing for the ENT business at Medtronic. “Recent studies suggest that bacteria are much bigger players in the inflammation associated chronic sinusitis and chronic otitis media. We’re optimistic that, when commercialised, we will be able to improve the removal of bacteria during sinus surgery and ventilation tube surgery.”

Several living tissue and safety studies are scheduled to start in the near future with subsequent submission for review by the FDA.

The study is published in the November issue of the American Journal of Rhinology.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo